Merit Medical Systems, Inc. (MMSI): Price and Financial Metrics


Merit Medical Systems, Inc. (MMSI)

Today's Latest Price: $43.56 USD

0.70 (-1.58%)

Updated May 28 6:55pm

Add MMSI to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

MMSI Stock Summary

  • MMSI's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 688.61 -- higher than 94.92% of US-listed equities with positive expected earnings growth.
  • Price to trailing twelve month operating cash flow for MMSI is currently 25.89, higher than 86.08% of US stocks with positive operating cash flow.
  • In terms of twelve month growth in earnings before interest and taxes, Merit Medical Systems Inc is reporting a growth rate of -89.88%; that's higher than merely 17.55% of US stocks.
  • Stocks that are quantitatively similar to MMSI, based on their financial statements, market capitalization, and price volatility, are QBAK, ELAN, TRUP, ENV, and NTCT.
  • MMSI's SEC filings can be seen here. And to visit Merit Medical Systems Inc's official web site, go to www.merit.com.
MMSI Daily Price Range
MMSI 52-Week Price Range

MMSI Stock Price Chart More Charts


MMSI Price/Volume Stats

Current price $43.56 52-week high $61.93
Prev. close $44.26 52-week low $19.50
Day low $43.41 Volume 439,500
Day high $45.26 Avg. volume 608,395
50-day MA $36.80 Dividend yield N/A
200-day MA $33.39 Market Cap 2.41B

Merit Medical Systems, Inc. (MMSI) Company Bio


Merit Medical Systems is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy. The company was founded in 1987 and is based in South Jordan, Utah.

MMSI Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$43.56$4.39-90%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Merit Medical Systems Inc. To summarize, we found that Merit Medical Systems Inc ranked in the 11th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 90%. As for the metrics that stood out in our discounted cash flow analysis of Merit Medical Systems Inc, consider:

  • Merit Medical Systems Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at 0.48. This coverage rate is greater than that of only 24.7% of stocks we're observing for the purpose of forecasting via discounted cash flows.
  • As a business, Merit Medical Systems Inc experienced a tax rate of about 0% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than just 0% of stocks generating free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-90%
1%-90%
2%-90%
3%-90%
4%-90%
5%-90%

Want more companies with a valuation profile/forecast similar to that of Merit Medical Systems Inc? See MYGN, RGEN, EHC, MOH, and CMD.


MMSI Latest News Stream


Event/TimeNews Detail
Loading, please wait...

MMSI Latest Social Stream


Loading social stream, please wait...

View Full MMSI Social Stream

Latest MMSI News From Around the Web

Below are the latest news stories about Merit Medical Systems Inc that investors may wish to consider to help them evaluate MMSI as an investment opportunity.

Merit Medical Announces Agreement With Starboard

Nominates Three Medical Device Industry Veterans – Lonny Carpenter, David Floyd and James Hogan – for Election to the Board of Directors Announces Formation of Operating.

Yahoo | May 26, 2020

Merit Medical Receives CE Mark for Wrapsody™ Endovascular Stent Graft System

The WRAPSODY system is a flexible self-expanding endoprosthesis indicated for use in hemodialysis patients for the treatment of stenosis or occlusion within central veins as well as the dialysis outflow circuit of an arteriovenous (AV) fistula or AV graft. Merit has worked for almost eight years to design, develop and establish the appropriate technology and manufacturing capabilities for this product. Merit recently completed enrollment and primary follow-up of its WRAPSODY FIRST study which included 46 patients in Europe.

Yahoo | May 26, 2020

Merit Medical (MMSI) Up 18.4% Since Last Earnings Report: Can It Continue?

Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Investment Research | May 23, 2020

Here's Why You Should Retain Merit Medical (MMSI) for Now

Investor confidence is high in Merit Medical (MMSI) stock, thanks to solid prospects.

Zacks Investment Research | May 19, 2020

Shareholder Alert: Robbins LLP Announces It Is Investigating Merit Medical Systems, Inc. (MMSI) for Misleading Shareholders

SAN DIEGO & SOUTH JORDAN, Utah--(BUSINESS WIRE)---- $MMSI #ClassAction--Shareholder rights law firm Robbins LLP announces that it is investigating Merit Medical Systems, Inc. (NASDAQ: MMSI) for alleged violations of the Securities Exchange Act of 1934 and whether the Company's officers and directors breached their fiduciary duties to shareholders. Merit manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutics. If you suffered a loss as a result of Merit's misconduct, click

Business Wire | May 7, 2020

Read More 'MMSI' Stories Here

MMSI Price Returns

1-mo 3.30%
3-mo 20.97%
6-mo 55.57%
1-year -18.58%
3-year 24.99%
5-year 111.87%
YTD 39.53%
2019 -44.06%
2018 29.19%
2017 63.02%
2016 42.55%
2015 7.27%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 1.414 seconds.